Marie-Clotilde Rissoan
Schering-Plough
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marie-Clotilde Rissoan.
Journal of Immunology | 2006
Bruno Salaun; Isabelle Coste; Marie-Clotilde Rissoan; Serge Lebecque; Toufic Renno
TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-β and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-κB downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.
Human Immunology | 2002
Francine Brière; Nathalie Bendriss-Vermare; Thomas Delale; Stéphanie Burg; Christophe Corbet; Marie-Clotilde Rissoan; Laurence Chaperot; Joel Plumas; Marie-Christine Jacob; Giorgio Trinchieri; Elizabeth E. M. Bates
Human plasmacytoid dendritic cells represent a rare population of leukocytes which produce high amounts of type I interferon in response to certain viruses. Although those cells were first described in 1958, there are still unsolved issues related to their origin and function. Recently, a leukemic counterpart of plasmacytoid dendritic cells was identified. Molecular approaches using either normal or leukemic plasmacytoid dendritic cells provide some new insights into the controversial lymphoid origin of those cells. The need for specific markers is still a critical aspect for the identification of plasmacytoid dendritic cells, whatever stage of differentiation, in normal as well as in pathological conditions. Hopefully, novel markers will allow delineation of the relationships between dendritic cells at different stages of differentiation/maturation along the myeloid and lymphoid lineages.
Science | 1999
Marie-Clotilde Rissoan; Vassili Soumelis; Norimitsu Kadowaki; Géraldine Grouard; Francine Brière; Rene de Waal Malefyt; Yong-Jun Liu
Journal of Experimental Medicine | 1997
Géraldine Grouard; Marie-Clotilde Rissoan; Luis Filgueira; Isabelle Durand; Jacques Banchereau; Yong-Jun Liu
Journal of Experimental Medicine | 1993
P Chomarat; Marie-Clotilde Rissoan; Jacques Banchereau; P Miossec
Blood | 2002
Marie-Clotilde Rissoan; Thomas Duhen; Jean-Michel Bridon; Nathalie Bendriss-Vermare; Catherine Peronne; Blandine de Saint Vis; Francine Brière; Elizabeth E. M. Bates
Journal of Immunology | 1995
P Chomarat; Edouard Vannier; J Dechanet; Marie-Clotilde Rissoan; Jacques Banchereau; Charles A. Dinarello; Pierre Miossec
Journal of Experimental Medicine | 2001
Norimitsu Kadowaki; Svetlana Antonenko; Stephen Ho; Marie-Clotilde Rissoan; Vassili Soumelis; Steven A. Porcelli; Lewis L. Lanier; Yong-Jun Liu
Blood | 2003
Remko Schotte; Marie-Clotilde Rissoan; Nathalie Bendriss-Vermare; Jean-Michel Bridon; Thomas Duhen; Kees Weijer; Francine Brière; Hergen Spits
Journal of Experimental Medicine | 1997
Chris G.F. Mueller; Marie-Clotilde Rissoan; Barbara Salinas; Smina Ait-Yahia; Odile Ravel; Jean-Michel Bridon; Francine Brière; Serge Lebecque; Yong-Jun Liu